Baseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated With First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Among epidermal growth factor receptor (EGFR) mutation status unknown nonsmall cell lung cancer (NSCLC) patients, those with higher carcinoembryonic antigen (CEA) level are more likely to response to EGFR-tyrosine kinase inhibitors (TKIs) because they tend to have mutant epidermal growth factor rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yu-Mu, Lai, Chien-Hao, Chang, Huang-Chih, Chao, Tung-Ying, Tseng, Chia-Cheng, Fang, Wen-Feng, Wang, Chin-Chou, Chung, Yu-Hsiu, Huang, Kuo-Tung, Chen, Hung-Cheng, Chang, Ya-Chun, Lin, Meng-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058911/
https://www.ncbi.nlm.nih.gov/pubmed/26683939
http://dx.doi.org/10.1097/MD.0000000000002239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058911/
https://www.ncbi.nlm.nih.gov/pubmed/26683939
http://dx.doi.org/10.1097/MD.0000000000002239

Ejemplares similares